CD4 and breast carcinoma: Cachot et al (54) extensively described CD4+ T cell clusters across different human cancers (melanoma, breast cancer, head and neck cancer, and hepatocellular carcinoma) that displayed cytotoxic properties with direct, contact- and granzyme-dependent lytic activity against autologous tumors.